In addition, it is not recommended if you have acute pancreatitis, severe allergic reaction to GLP-1 drugs, are pregnant, or have gastroparesis and inflammatory bowel disease
Sustained Weight Loss Most patients see 15 to 20 percent body weight reduction over 12 to 18 months with semaglutide or tirzepatide, paired with our structured monitoring program
The chosen target focuses on durable behavior change rather than achieving only short-term blood sugar control
Lorenz M, Evers A, Wagner M (2013) Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity
It helps the body reset, particularly during hormonal transitions like perimenopause and menopause , and provides a safe, structured way to support long-term wellbeing
These two also have a sparing effect upon each other